USE OF A CHEMICAL COMPOUND

Document Type: 
Collection: 
Document Number (FOIA) /ESDN (CREST): 
00184420
Release Decision: 
RIPPUB
Original Classification: 
U
Document Page Count: 
1
Document Creation Date: 
January 21, 2025
Document Release Date: 
January 15, 1983
Sequence Number: 
Case Number: 
Publication Date: 
January 15, 1952
File: 
Body: 
15 January 1952 � � /7 MEDDRAUDUM FOR: ' ) TO SUBJECT : Use of a Chemical Compound 1. About a month ago, asked me if we could give him apy information on nicotinic acid: We have made a number of discreet inquiries and have turned up information as noted herein. This in- formation comes from one of the most prominent pharmacologists in the United States. We are making further inquiries of sources recomrended 14y the individual who provided this information. One source in par- ticlilar is reported to be doing research in nicotinic acid and we may obtain even more useful information. Os I! 2. The information provided is as follows: The common use of nicotinic acid is as a vitamin; it is used principally as a preventrtive for pellagra (a skin affection with severe constitutional and nervous symptons) in the southern part of the.US. Its therapeutic action in these cases is in developing a psychosis and dilating the blood vessels. Since nicotinic acid is a peripheral dilator of blood vessels, it might also to used in the treatment of frost bite but there is no published indication that this type of therapy has ever been developed anywhere. His staff has done much work on using a combination of nicotinomid with privino for the treatment of schizophrenic patients. Privine is a nicotinic acid inhibitor (B 45) ands although very lethal in animals, is not poisonous for human-beings. The nicotinomidiorivino combination produces a shock reaction uhich does not involve convulsions. Ex- periments in this have been made on patients at a State Hospital nearby but are no longer being 'carried an because of the lack of funds and the difficulty in travel between the medical college laboratories rnd'the hospital. The source did not know of other doctors or laboratories in the US or abroad who were working with this nicotinomid- privine combination or other nicotinic acid compounds. He could not recall having seen any publications on this subject. ,